Jed A. Latkin

2019

In 2019, Jed A. Latkin earned a total compensation of $739.9K as Chief Executive Officer, Chief Operating Officer and Chief Financial Officer at Navidea Biopharmaceuticals, a 16% increase compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$178,143
Option Awards$81,200
Salary$475,000
Other$5,600
Total$739,943

Latkin received $475K in salary, accounting for 64% of the total pay in 2019.

Latkin also received $178.1K in non-equity incentive plan, $81.2K in option awards and $5.6K in other compensation.

Rankings

In 2019, Jed A. Latkin's compensation ranked 10,512th out of 13,971 executives tracked by ExecPay. In other words, Latkin earned more than 24.8% of executives.

ClassificationRankingPercentile
All
10,512
out of 13,971
25th
Division
Manufacturing
4,248
out of 5,701
26th
Major group
Chemicals And Allied Products
1,645
out of 2,200
25th
Industry group
Drugs
1,410
out of 1,886
25th
Industry
In Vitro and In Vivo Diagnostic Substances
45
out of 77
42nd
Source: SEC filing on July 31, 2020.

Latkin's colleagues

We found two more compensation records of executives who worked with Jed A. Latkin at Navidea Biopharmaceuticals in 2019.

2019

Joel Kaufman

Navidea Biopharmaceuticals

Chief Business Officer

2019

Michael Rosol

Navidea Biopharmaceuticals

Chief Medical Officer

News

You may also like